Albert Christian Ludolph, Prof.: Clinical Trials

2 trials sponsored by Albert Christian Ludolph, Prof., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Completed 1

Follow Albert Christian Ludolph, Prof.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS)
high-caloric fatty diet, ultra-high-caloric fatty diet, ultra-high-caloric carbohydrate-rich diet - Amyotrophic Lateral Sclerosis
Phase 1CompletedAlbert Christian Ludolph, Prof.642019-11-262021-04-29
Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis
Immunoadsorption, Plasmapheresis - Multiple Sclerosis, Clinically Isolated Syndrome
Not applicableCompletedAlbert Christian Ludolph, Prof.612016-02-262019-09-11

Conditions studied

Amyotrophic Lateral Sclerosis (1)  ·  Multiple Sclerosis (1)

Interventions

Plasmapheresis (1)

Countries

Germany (2)

Top investigators

Johannes Dorst, PD Dr. (1)

Results publications

PMID 31832624, PMID 38700322